H-DL-Ala-DL-Glu-DL-xiThr-DL-xiThr-DL-Ser-DL-Phe-DL-Ser-DL-Leu-DL-xiThr-DL-Lys-DL-Phe-DL-Val-DL-Pro-DL-Asp-DL-Glu-DL-Leu-OH
| Internal ID | 252e1084-e081-4abc-a266-3509674459a8 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics |
| IUPAC Name | 2-[[2-[[2-[[1-[2-[[2-[[6-amino-2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-(2-aminopropanoylamino)-4-carboxybutanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-phenylpropanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-4-methylpentanoic acid |
| SMILES (Canonical) | CC(C)CC(C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)N2CCCC2C(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CO)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)N |
| SMILES (Isomeric) | CC(C)CC(C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)N2CCCC2C(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CO)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)N |
| InChI | InChI=1S/C81H125N17O28/c1-39(2)32-51(87-74(118)56(37-99)92-70(114)52(34-46-20-13-11-14-21-46)89-75(119)57(38-100)93-78(122)64(44(9)102)97-79(123)65(45(10)103)95-69(113)50(27-29-60(106)107)84-66(110)42(7)83)72(116)96-63(43(8)101)77(121)86-48(24-17-18-30-82)67(111)88-53(35-47-22-15-12-16-23-47)73(117)94-62(41(5)6)80(124)98-31-19-25-58(98)76(120)90-54(36-61(108)109)71(115)85-49(26-28-59(104)105)68(112)91-55(81(125)126)33-40(3)4/h11-16,20-23,39-45,48-58,62-65,99-103H,17-19,24-38,82-83H2,1-10H3,(H,84,110)(H,85,115)(H,86,121)(H,87,118)(H,88,111)(H,89,119)(H,90,120)(H,91,112)(H,92,114)(H,93,122)(H,94,117)(H,95,113)(H,96,116)(H,97,123)(H,104,105)(H,106,107)(H,108,109)(H,125,126) |
| InChI Key | DHKZHXVJZLGNRL-UHFFFAOYSA-N |
| Popularity | 1 reference in papers |
| Molecular Formula | C81H125N17O28 |
| Molecular Weight | 1785.00 g/mol |
| Exact Mass | 1783.88799640 g/mol |
| Topological Polar Surface Area (TPSA) | 730.00 Ų |
| XlogP | -8.10 |
| Atomic LogP (AlogP) | -7.11 |
| H-Bond Acceptor | 26 |
| H-Bond Donor | 25 |
| Rotatable Bonds | 56 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.5866 | 58.66% |
| Caco-2 | - | 0.8618 | 86.18% |
| Blood Brain Barrier | - | 0.8000 | 80.00% |
| Human oral bioavailability | - | 0.6571 | 65.71% |
| Subcellular localzation | Mitochondria | 0.5223 | 52.23% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8702 | 87.02% |
| OATP1B3 inhibitior | + | 0.9345 | 93.45% |
| MATE1 inhibitior | - | 0.9800 | 98.00% |
| OCT2 inhibitior | - | 0.8750 | 87.50% |
| BSEP inhibitior | + | 0.9707 | 97.07% |
| P-glycoprotein inhibitior | + | 0.7417 | 74.17% |
| P-glycoprotein substrate | + | 0.8473 | 84.73% |
| CYP3A4 substrate | + | 0.7257 | 72.57% |
| CYP2C9 substrate | - | 0.7984 | 79.84% |
| CYP2D6 substrate | - | 0.8047 | 80.47% |
| CYP3A4 inhibition | - | 0.5917 | 59.17% |
| CYP2C9 inhibition | - | 0.9028 | 90.28% |
| CYP2C19 inhibition | - | 0.7265 | 72.65% |
| CYP2D6 inhibition | - | 0.8857 | 88.57% |
| CYP1A2 inhibition | - | 0.9278 | 92.78% |
| CYP2C8 inhibition | + | 0.5285 | 52.85% |
| CYP inhibitory promiscuity | - | 0.8318 | 83.18% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8400 | 84.00% |
| Carcinogenicity (trinary) | Non-required | 0.6385 | 63.85% |
| Eye corrosion | - | 0.9903 | 99.03% |
| Eye irritation | - | 0.8954 | 89.54% |
| Skin irritation | - | 0.8068 | 80.68% |
| Skin corrosion | - | 0.9367 | 93.67% |
| Ames mutagenesis | - | 0.9100 | 91.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7162 | 71.62% |
| Micronuclear | + | 0.7900 | 79.00% |
| Hepatotoxicity | + | 0.5023 | 50.23% |
| skin sensitisation | - | 0.8992 | 89.92% |
| Respiratory toxicity | + | 0.9222 | 92.22% |
| Reproductive toxicity | + | 0.9222 | 92.22% |
| Mitochondrial toxicity | + | 0.9125 | 91.25% |
| Nephrotoxicity | - | 0.6528 | 65.28% |
| Acute Oral Toxicity (c) | III | 0.6475 | 64.75% |
| Estrogen receptor binding | - | 0.5000 | 50.00% |
| Androgen receptor binding | + | 0.7031 | 70.31% |
| Thyroid receptor binding | + | 0.7766 | 77.66% |
| Glucocorticoid receptor binding | + | 0.8293 | 82.93% |
| Aromatase binding | + | 0.7812 | 78.12% |
| PPAR gamma | + | 0.7941 | 79.41% |
| Honey bee toxicity | - | 0.8101 | 81.01% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.6700 | 67.00% |
| Fish aquatic toxicity | + | 0.7494 | 74.94% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.94% | 98.95% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 99.75% | 98.33% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.63% | 96.61% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 99.57% | 90.17% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.22% | 83.82% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 99.06% | 98.10% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.97% | 96.09% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 98.35% | 100.00% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 97.92% | 90.20% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 97.80% | 93.56% |
| CHEMBL4801 | P29466 | Caspase-1 | 97.76% | 96.85% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 97.32% | 96.67% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 95.50% | 98.94% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 95.44% | 97.09% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 95.41% | 100.00% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 95.25% | 100.00% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 94.80% | 99.17% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 94.68% | 96.67% |
| CHEMBL3468 | P55210 | Caspase-7 | 94.19% | 95.68% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 93.86% | 95.56% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 93.85% | 97.64% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 93.51% | 91.11% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 92.95% | 93.00% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 92.56% | 89.63% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 92.52% | 88.42% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 91.87% | 97.50% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 91.72% | 96.00% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 91.31% | 97.14% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 91.14% | 98.24% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 91.11% | 96.47% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 91.08% | 98.89% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 90.83% | 96.03% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 90.60% | 93.10% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 89.55% | 92.80% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 88.79% | 99.77% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 88.68% | 97.43% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 88.12% | 97.23% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 87.44% | 82.38% |
| CHEMBL5028 | O14672 | ADAM10 | 86.73% | 97.50% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 86.41% | 95.89% |
| CHEMBL3776 | Q14790 | Caspase-8 | 86.21% | 97.06% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 86.11% | 93.18% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 85.69% | 93.33% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 85.46% | 90.71% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 85.30% | 91.19% |
| CHEMBL4071 | P08311 | Cathepsin G | 84.98% | 94.64% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 84.97% | 95.89% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 84.62% | 95.52% |
| CHEMBL3004 | P33527 | Multidrug resistance-associated protein 1 | 83.58% | 96.37% |
| CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 82.13% | 97.86% |
| CHEMBL5805 | Q9NR97 | Toll-like receptor 8 | 81.82% | 96.25% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 81.42% | 90.08% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 81.30% | 94.45% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 81.17% | 95.00% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 80.97% | 94.66% |
| CHEMBL2319 | P06870 | Kallikrein 1 | 80.23% | 90.95% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| Phaseolus acutifolius |
| PubChem | 75290577 |
| LOTUS | LTS0132494 |
| wikiData | Q104980316 |